Physician profile
Mario Oliver
NPI 1124327606
$4,653.64
in general payments reported to CMS, 2019-2025
29 companies · $1,081 in 2025
The $1,081 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $156 · 2021: $652 · 2022: $687 · 2023: $720 · 2024: $1,000 · 2025: $1,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,800.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $803.31 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $750.75 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals Lp | $718.76 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $302.29 | 2021-2025 | Jardiance, Tradjenta |
| Glaxosmithkline, LLC. | $278.91 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Abbvie INC. | $253.78 | 2019-2025 | |
| Pfizer INC. | $196.53 | 2020-2025 | |
| Stryker Corporation | $182.08 | 2021-2022 | |
| Amgen INC. | $148.24 | 2019-2025 | Evenity |
| Abbott Laboratories | $145.71 | 2022-2025 | Freestyle Libre 3 |
| Cranial Technologies, INC | $110.47 | 2020-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $86.83 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $86.06 | 2021 | |
| Inspire Medical Systems, INC. | $74.92 | 2025 | Inspire |
| Therapeuticsmd, INC. | $65.54 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $56.07 | 2019-2020 | |
| Exact Sciences Corporation | $50.22 | 2024 | Cologuard Collection Kit |
| Ironshore Pharmaceuticals INC. | $48.93 | 2022 | |
| Edwards Lifesciences Corporation | $39.98 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Biohaven Pharmaceutical Holding Company Ltd. | $38.99 | 2022 | |
| Janssen Pharmaceuticals, INC | $32.72 | 2019-2020 | |
| Hologic Sales and Service, LLC | $31.14 | 2024 | Aptima |
| Si-Bone, INC. | $24.69 | 2019 | |
| Genentech USA, INC. | $24.59 | 2021 | |
| Astellas Pharma US INC | $24.38 | 2024 | Veozah |
| Fidia Pharma USA INC. | $22.84 | 2024 | Hymovis, Triluron, Hyalgan |
| Organon LLC | $21.91 | 2023 | Nexplanon |
| Tactile Systems Technology INC | $18.03 | 2022 | |
| Daiichi Sankyo INC. | $14.97 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.